INSURANCE AUSTRALIA GROUP LIMITED (IAG)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

IAG

IAG - INSURANCE AUSTRALIA GROUP LIMITED

FNArena Sector : Insurance
Year End: June
GICS Industry Group : Insurance
Debt/EBITDA: N/A
Index: ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS

Insurance Australia Group is an insurance company formed by the demutualisation of the NRMA Insurance business in July 2000. It is not a customer-facing brand, but an umbrella organisation that holds many well known insurance brands in Australia, NZ and Asia, incl NRMA Insurance and CGU.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$7.89

20 Feb
2025

0.200

OPEN

$7.74

2.60%

HIGH

$7.89

12,159,047

LOW

$7.72

TARGET
$8.653 9.7% upside
Franking for last dividend paid out: 60%
OTHER COMPANIES IN THE SAME SECTOR
AUB . CVW . FCL . GDG . HLI . MPL . NHF . NOL . QBE . SDF . SUN . TWR .
FNARENA'S MARKET CONSENSUS FORECASTS
IAG: 1
Title FY23
Actual
FY24
Actual
FY25
Forecast
FY26
Forecast
EPS (cps) xxx 37.3 45.4 xxx
DPS (cps) xxx 27.0 30.3 xxx
EPS Growth xxx 10.0% 21.8% xxx
DPS Growth xxx 80.0% 12.3% xxx
PE Ratio xxx N/A 17.2 xxx
Dividend Yield xxx N/A 3.9% xxx
Div Pay Ratio(%) xxx 72.4% 66.7% xxx

Dividend yield today if purchased 3 years ago: 5.56%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

3.46

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 29/08 - ex-div 17c (franking 50%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx37.3
DPS All xxxxxxxxxxxxxxx27.0
Sales/Revenue xxxxxxxxxxxxxxx16,325.0 M
Book Value Per Share xxxxxxxxxxxxxxx281.0
Net Operating Cash Flow xxxxxxxxxxxxxxx1,800.0 M
Net Profit Margin xxxxxxxxxxxxxxx5.50 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx13.49 %
Return on Invested Capital xxxxxxxxxxxxxxx9.58 %
Return on Assets xxxxxxxxxxxxxxx2.96 %
Return on Equity xxxxxxxxxxxxxxx13.49 %
Return on Total Capital xxxxxxxxxxxxxxx16.98 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx703.0 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx70 M
Long Term Debt xxxxxxxxxxxxxxx2,867 M
Total Debt xxxxxxxxxxxxxxx2,937 M
Goodwill - Gross xxxxxxxxxxxxxxx2,821 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx1,841 M
Price To Book Value xxxxxxxxxxxxxxx2.54

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx637.0 M
Capex % of Sales xxxxxxxxxxxxxxx3.90 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx1,873 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx11,695 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.4

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

14/02/2025

1

Outperform

$8.50

7.73%

Insurance Australia Group has retained margin guidance for FY25 despite a strong improvement in the first half, which Macquarie suspects signals conservatism around the pricing outlook.

Gross written premium growth has been downgraded towards the lower end of the previous "mid-to-high single digit" range.

As the premium rate cycle continues to earn and there are benefits from higher interest rates, Macquarie retains an Outperform rating. Target edges down to $8.50 from $8.70.

FORECAST
Macquarie forecasts a full year FY25 dividend of 26.00 cents and EPS of 42.30 cents.
Macquarie forecasts a full year FY26 dividend of 30.00 cents and EPS of 42.40 cents.

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Goldman Sachs

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Jarden

17/02/2025

2

Overweight

$8.00

1.39%

Insurance Australia Group delivered a beat to expectations in its first half, with Jarden noting the benefits from a benign catastrophe environment as well as expansion in the retail and NZ portfolios.

With gross written premium guidance downgraded on the back of a sharp tapering in inflation, the main issue for the broker is how the company can grow earnings in the medium term.

Near-term earnings are expected to remain well supported and there is the capacity to trade pricing for volume in the medium term so an Overweight rating is retained. Target is reduced to $8.00 from $8.40.

FORECAST
Jarden forecasts a full year FY25 dividend of 31.00 cents and EPS of 44.00 cents.
Jarden forecasts a full year FY26 dividend of 32.00 cents and EPS of 43.20 cents.

IAG STOCK CHART